Nat Rev Neurol 15(10):565581
References References Pickart, L., & Margolina, A
Typical Duration of Therapy The duration of BPC-157 therapy varies based on the conditions severity: Acute injuries or mild inflammation: 24 weeks Moderate injuries or post-surgical recovery: 48 weeks Chronic or systemic conditions: 812 weeks or longer For best outcomes, BPC-157 may be combined with TB-500, Thymosin Beta-4, or KPV peptides, along with targeted nutrition and physiologic optimization
Improves brain focus: Enhanced synaptic transmission and neuroplasticity support sustained attention and mental clarity
BPC-157, or Body Protection Compound 157, is a peptide known for its remarkable ability to promote healing and repair tissues
The limitations Rogan acknowledges Despite his enthusiasm, Rogan doesn't claim peptides are miracle drugs